US 2004/0167109 A1 · Formulations of glucocorticoids to treat pathologic ocular angiogenesis

Abstract

Formulations of glucocorticoids alone and in combination with anecortave acetate are useful for preventing and treating pathologic ocular angiogenesis and associated edema.

Claims2

Dependent claims

A method for treating pathologic ocular angiogenesis and any associated edema which comprises, administering a composition comprising an effective amount of a glucocorticoid.

Dependencies are inferred from the claim text.

Facts

Application

10/772,963Filed 5 Feb 2004

Priority

20 Feb 2003

Published

26 Aug 2004

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/58
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids: containing heterocyclic rings, e.g. danazol,…
A61K 31/573
Substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone: substituted in position 21, e.g. cortisone,…
A61P 9/00
Drugs for disorders of the cardiovascular system
A61P 9/10
Drugs for disorders of the cardiovascular system: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary…

Abstract

Formulations of glucocorticoids alone and in combination with anecortave acetate are useful for preventing and treating pathologic ocular angiogenesis and associated edema.

Formulations of glucocorticoids to treat pathologic ocular angiogenesis

Life of this patent

Abstract

Claims2

Formulations of glucocorticoids to treat pathologic ocular angiogenesis

Life of this patent

Abstract

Claims2